Johnson & Johnson Loses Bid for Stay in Appealing Faulty Hip Device Case
Depuy Faulty hip device update
October 6, 2017
Johnson & Johnson and its subsidiary DePuy Orthopaedics have lost their bid to have the First Circuit Court stay a decision over their allegedly defective hip replacement devices under the terms of the False Claims Act.
Antoni Nargol and David Langton, two consumer-advocate whistleblowers, have alleged that DePuy’s metal-on-metal hip replacement devices are dangerously faulty, yet the company nevertheless made direct claims for the device to federal and state healthcare agencies. Those false claims, the suit alleges, thereby indirectly caused physicians themselves to make false claims to the government. The suit had been tossed last year but was revived in July.
Johnson & Johnson and DePuy had hoped to delay the court’s decision as they prepare to appeal the case to the U.S. Supreme Court, but that motion was formally denied.
The metal-on-metal construction of many hip replacement devices – including several manufactured by Johnson & Johnson and DePuy – has been implicated in a number of serious health problems. Tiny fragments of metal can be released by the movement of the artificial hip joints, and those fragments can then enter the bloodstream, causing infection, inflammation, organ damage, and, in some cases, death.
The case will now move on to the U.S. Supreme Court.
If you have a hip replacement device and it has caused pain, discomfort, or health complications, you may be entitled to significant financial compensation. To inquire about how to start a lawsuit over a defective hip device, contact the expert attorneys at TheLawFirm.com. The consultation is free.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!